Evonik Evonik

X

CAS 3891-07-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 3891-07-4
Also known as: 3891-07-4, 2-phthalimidoethanol, 2-(2-hydroxyethyl)isoindoline-1,3-dione, N-hydroxyethylphthalimide, 1h-isoindole-1,3(2h)-dione, 2-(2-hydroxyethyl)-, 2-(2-hydroxyethyl)isoindole-1,3-dione
Molecular Formula
C10H9NO3
Molecular Weight
191.18  g/mol
InChI Key
MWFLUYFYHANMCM-UHFFFAOYSA-N
FDA UNII
61842K53O1

1 2D Structure

CAS 3891-07-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(2-hydroxyethyl)isoindole-1,3-dione
2.1.2 InChI
InChI=1S/C10H9NO3/c12-6-5-11-9(13)7-3-1-2-4-8(7)10(11)14/h1-4,12H,5-6H2
2.1.3 InChI Key
MWFLUYFYHANMCM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC=C2C(=C1)C(=O)N(C2=O)CCO
2.2 Other Identifiers
2.2.1 UNII
61842K53O1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-hydroxyethylphtalimide

2. 2-hydroxyethylphthalimide

3. 2-hydroxyethylphthalimide, 15n-labeled

2.3.2 Depositor-Supplied Synonyms

1. 3891-07-4

2. 2-phthalimidoethanol

3. 2-(2-hydroxyethyl)isoindoline-1,3-dione

4. N-hydroxyethylphthalimide

5. 1h-isoindole-1,3(2h)-dione, 2-(2-hydroxyethyl)-

6. 2-(2-hydroxyethyl)isoindole-1,3-dione

7. 2-hydroxyethylphthalimide

8. Phthalimide, N-(2-hydroxyethyl)-

9. Mfcd00005903

10. Phthalimide, N-2-hydroxyethyl-

11. 2-(2-hydroxyethyl)-2,3-dihydro-1h-isoindole-1,3-dione

12. 2-(2-hydroxyethyl)-1h-isoindole-1,3(2h)-dione

13. Nsc 2773

14. Nsc-2773

15. Nsc 50624

16. Nsc-50624

17. 2-(2-hydroxy-ethyl)-isoindole-1,3-dione

18. 61842k53o1

19. N-[2-hydroxyethyl]phthalimide

20. 1h-isoindole-1, 2-(2-hydroxyethyl)-

21. N-hydroxyethylphthalmde

22. N-2-hydroxyethyl Phthalimide

23. Oprea1_140654

24. Oprea1_661592

25. Schembl64902

26. N-(2-hydroxyethyl)-phtalimide

27. Amy364

28. N-(2-hydroxyethyl)-phthalimide

29. Dtxsid1063225

30. Mwfluyfyhanmcm-uhfffaoysa-

31. Nsc2773

32. [n-{2-hydroxyethyl}] Phthalimide

33. Unii-61842k53o1

34. N-(.beta.-hydroxyethyl)phthalimide

35. Nsc50624

36. Einecs 223-434-4

37. Bbl036039

38. Stl356371

39. N-(2-hydroxyethyl)phthalimide, 99%

40. Akos000119922

41. Ab00540

42. Cs-w021382

43. 2-(n-phthalimidyl)ethyl Alcohol

44. S12314

45. 2-(2-hydroxyethyl) Isoindole-1,3-dione

46. 2-(2-hydroxyethyl)-1,3-isoindolinedione

47. Ac-29753

48. Sy048556

49. Ai3-02622

50. Bb 0218473

51. Ft-0676029

52. H0245

53. En300-18323

54. Ec 223-434-4

55. 2-(2-hydroxyethyl)-1h-isoindol-1,3(2h)-dione

56. A925203

57. 2-(2-hydroxyethyl)-1h-isoindole-1,3 (2h)-dione

58. J-523590

59. Q27263319

60. Z57902232

61. F0433-0457

62. Inchi=1/c10h9no3/c12-6-5-11-9(13)7-3-1-2-4-8(7)10(11)14/h1-4,12h,5-6h2

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 191.18 g/mol
Molecular Formula C10H9NO3
XLogP30.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area57.6
Heavy Atom Count14
Formal Charge0
Complexity240
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and bus...
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
Flag India
Digital Content Digital Content
14205-39-1
Amlodipine Besylate
"The Company’s product portfolio includes a wide range of products such as Acetyl Intermediates, Specia...
"The Company’s product portfolio includes a wide range of products such as Acetyl Intermediates, Speciality Intermediates, and Fluorine Intermediates. These products serve diverse applications, spanning industries from pharmaceuticals to packaging and extending to agrochemicals, along with paints, coatings, and dyes. With local presence in Europe and China, the Company has a strong presence in the international markets.
Since its inception, the company has maintained a constant focus on quality, innovation, sustainability, customer centricity which has enabled it to become a reliable partner for its customers.
Laxmi Organic

18th WRIB

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Besylate
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in deliveri...
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in deliveri...
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over ...
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
103129-82-4
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-75-8
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-75-8
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY